Lexicon Pharmaceuticals, Inc. (LXRX)
Market Closed
10 Sep, 20:00
NASDAQ (CM) NASDAQ (CM) Primary 
XMUN $
2. 02
-0.13
-6.0465%
Pre Market
$
+0.11 +5.4455% 2. 13
990.56M Market Cap
- P/E Ratio
- Div Yield
2.94M Volume
-0.71 Eps
$ 2.15
Previous Close 
Want to track LXRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Lexicon Pharmaceuticals, Inc. (LXRX) Statistics
Valuation metrics
Market Cap 990.56M
Enterprise value 1.01B
Trailing P/E (ttm) -14.89
Forward P/E -
PEG ratio 0.12
Price/Sales (ttm) 23.99
Price/Book (mrq) 5.62
Enterprise Value/Revenue 24.44
Enterprise Value/EBITDA -19.39
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.12M
Average volume (90 days) 5.73M
Price summary
52-Week low 1.06
52-Week high 2.68
Beta -
50-Day moving average 2.32
200-Day moving average 1.83
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:7
Last split Date 21 May 2015
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -1.47%
Operating margin -1.31%
Operational effectiveness
Return on assets -0.24%
Return on equity -0.4%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.09
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.14
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.44
Total debt (mrq) -
Total Debt/Equity (mrq) 0.34
Current ratio (mrq) 13.37%
Book value per share (mrq) 0.4
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
